Home › Funds › Royce & Associates › XENE
Royce & Associates position in XENE
XENON PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)65.03K sh
Reported value held$3.93M
Portfolio Weight0.03%
First reportedQ2 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 65.03K | $3.93M | New |
Other funds holding XENE
- Fidelity Management & Research (FMR) 9.65M sh · $582.35M · Q2 2026
- BlackRock Inc 7.52M sh · $454.06M · Q2 2026
- Janus Henderson Group 4.18M sh · $242.86M · Q1 2026
- JPMorgan Chase & Co 2.62M sh · $157.38M · Q2 2026
- Two Sigma Investments 1.64M sh · $99.16M · Q2 2026
- Franklin Resources 1.44M sh · $86.78M · Q2 2026
- Wellington Management Group 1.43M sh · $86.04M · Q2 2026
- Geode Capital Management 1.37M sh · $82.69M · Q2 2026
- Invesco Ltd 903.46K sh · $54.53M · Q2 2026
- Capital World Investors 862.77K sh · $52.08M · Q2 2026
- Goldman Sachs Group 773.62K sh · $46.70M · Q2 2026
- Marshall Wace 689.34K sh · $41.61M · Q2 2026